- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostatic Neoplasms, Castration-Resistant in Switzerland
Total 113 results
-
Thomas ZilliActive, not recruitingMalignant Neoplasm of Prostate | Local DiseaseNetherlands, Israel, Switzerland, Spain, Belgium, Finland, Portugal, Turkey
-
Swiss Group for Clinical Cancer ResearchCompletedProstate CancerSwitzerland
-
Dominik AbtRecruitingProstate Cancer | Bladder Outlet ObstructionSwitzerland
-
Swiss Group for Clinical Cancer ResearchCompleted
-
Zurich University of Applied SciencesCompleted
-
ABX advanced biochemical compounds GmbHActive, not recruitingProstate Cancer | Prostate Cancer RecurrentUnited States, Netherlands, Switzerland
-
Swiss Group for Clinical Cancer ResearchTerminatedProstate Cancer | Cancer of the ProstateSwitzerland
-
Kantonsspital GraubuendenCompletedLymph Node Disease | Radiotherapy Side Effect | Prostatic Neoplasms BenignSwitzerland
-
European Organisation for Research and Treatment...CompletedProstate CancerFrance, Spain, Belgium, Switzerland, Israel, Germany
-
Swiss Group for Clinical Cancer ResearchCompletedProstate CancerSwitzerland
-
Med Discovery SACompleted
-
Gustave Roussy, Cancer Campus, Grand ParisNational Cancer Institute, FranceRecruitingProstate CancerFrance, Switzerland
-
Swiss Group for Clinical Cancer ResearchTerminatedProstate CancerSwitzerland, Germany, France
-
Novartis PharmaceuticalsRecruitingOligometastatic Prostate Cancer (OMPC)Japan, Singapore, Canada, Israel, Switzerland, Australia, United States
-
Swiss Group for Clinical Cancer ResearchTerminatedProstate Cancer | Prostate Cancer MetastaticFrance, Switzerland, Spain, Italy
-
University GhentUniversity Hospital, GenevaActive, not recruitingProstate Cancer | Metastatic Cancer | Prostate Cancer Metastatic | Oligometastatic CancerNorway, Spain, Belgium, Switzerland, Australia, Italy
-
CureVacTerminatedTrial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate CancerProstate CancerFrance, Czech Republic, Germany, Poland, Spain, Sweden, Switzerland, United Kingdom
-
European Organisation for Research and Treatment...CompletedProstate Cancer | Metastatic CancerNetherlands, Denmark, Belgium, Poland, Switzerland, United Kingdom, Italy, Russian Federation, Portugal
-
Saving Patients' Lives Medical B.V.Radboud University Medical Center; ABX-CRO advanced pharmaceutical services... and other collaboratorsRecruitingProstate Cancer | Metastasis | ProstatectomyGermany, Belgium, Netherlands, Switzerland
-
Advanced Medical Diagnostics s.a.TerminatedProstate CancerAustria, Belgium, Bulgaria, Czech Republic, Denmark, Estonia, France, Germany, Hungary, Italy, Latvia, Lithuania, Netherlands, Russian Federation, Spain, Switzerland, Turkey, United Kingdom
-
Novartis PharmaceuticalsCompletedProstatic Neoplasms | Prostate CancerSpain, Italy, France, Switzerland, United States
-
Steba Biotech S.A.CompletedProstate CancerSpain, France, Germany, Netherlands, United Kingdom, Belgium, Finland, Italy, Sweden, Switzerland
-
GlaxoSmithKlineCompletedNeoplasms, ProstateUnited States, Australia, France, Germany, Spain, Bulgaria, Estonia, Italy, Poland, Netherlands, Belgium, United Kingdom, Canada, Denmark, Ukraine, Finland, Latvia, Russian Federation, Greece, Slovenia, Brazil, Mexico, Slovakia, Japan, Puerto... and more
-
AstraZenecaCompletedProstate CancerSweden, United States, Australia, France, United Kingdom, Poland, Finland, Netherlands, Norway, Belgium, Canada, Indonesia, Denmark, Switzerland
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingMetastatic Breast Cancer | Bone Metastases | Metastatic Prostate CancerSwitzerland, Germany, Austria
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingProstate CancerSwitzerland, Belgium, Germany
-
Novartis PharmaceuticalsCompletedRecurrence | Prostatic Neoplasms | Prostate CancerSpain, France, Switzerland, United States
-
UNICANCERSanofi; European Organisation for Research and Treatment of Cancer - EORTC; I... and other collaboratorsActive, not recruitingMetastatic Prostate CancerFrance, Ireland, Spain, Switzerland, Belgium, Italy, Romania
-
Ferring PharmaceuticalsCompletedProstate CancerUnited Kingdom, Netherlands, Ireland, Greece, France, Belgium, Denmark, Norway, Italy, Slovakia, Switzerland, Portugal, Finland, Hungary, Germany
-
European Organisation for Research and Treatment...Active, not recruitingProstate CancerGermany, Spain, France, Belgium, United Kingdom, Switzerland, Italy, Denmark
-
Prostate Cancer Clinical Trials ConsortiumRecruitingProstate CancerUnited States, Australia, Spain, Switzerland, United Kingdom, Kenya, Canada, Ireland, Barbados, Brazil, Jamaica, Nigeria, Norway, Sweden, South Africa
-
Janssen Pharmaceutica N.V., BelgiumCompletedProstate CancerFrance, Poland, United Kingdom, Belgium, Germany, Spain, Israel, Portugal, Slovenia, Turkey, Sweden, Austria, Russian Federation, Luxembourg, Switzerland
-
Swiss Group for Clinical Cancer ResearchCantonal Hospital of St. Gallen; ProteoMediX AGActive, not recruiting
-
Boston Scientific CorporationRecruitingProstate CancerAustralia, Spain, United Kingdom, United States, Germany, Ireland, France, Italy, Switzerland
-
AstraZenecaCompletedProstate CancerSweden, United States, Brazil, France, Peru, Spain, United Kingdom, Germany, Poland, Romania, Finland, Canada, Argentina, Australia, South Africa, Czech Republic, India, Netherlands, Italy, Switzerland, Korea, Republic of, Hungary, ... and more
-
AbbottCompletedProstate CancerUnited States, Canada, France, Spain, Belgium, Australia, United Kingdom, Italy, Sweden, South Africa, Netherlands, Ireland, Germany, Austria, New Zealand, Greece, Poland, Switzerland
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States, France, Ukraine, United Kingdom, Belgium, Germany, Taiwan, Spain, Belarus, Israel, Portugal, Bulgaria, Romania, South Africa, Japan, Switzerland, Canada, Australia, Netherlands, Greece, Chile, New Zealand, Peru, Singapore, Russian Federation and more
-
AstraZenecaTerminatedProstate CancerSweden, United States, Brazil, Czech Republic, France, Italy, Peru, Russian Federation, Spain, Turkey, United Kingdom, Germany, China, Hungary, Latvia, Poland, Romania, Japan, Finland, Norway, Canada, South Africa, Argentina, Australia, Belgiu... and more
-
Medical Research CouncilActive, not recruitingProstate CancerUnited Kingdom, Switzerland
-
European Organisation for Research and Treatment...Bayer; Latin American Cooperative Oncology Group; UNICANCER; Astellas Pharma Europe... and other collaboratorsActive, not recruitingProstate CancerSpain, Belgium, France, Italy, United Kingdom, Denmark, Canada, Ireland, Brazil, Norway, Poland, Switzerland
-
AmgenRecruitingProstate CancerJapan, United States, Korea, Republic of, Taiwan, Australia, Spain, Germany, Switzerland, China, Portugal
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Stage II Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma | Stage I Prostate AdenocarcinomaUnited States, Canada, Switzerland
-
AstraZenecaCompletedProstate CancerSweden, United States, Brazil, Czech Republic, France, Russian Federation, United Kingdom, Germany, China, Hungary, Poland, Finland, Netherlands, Mexico, Hong Kong, Australia, Belgium, Canada, Denmark, Portugal, South Africa, Korea... and more
-
AstraZenecaDaiichi SankyoRecruitingGastric Cancer | Colorectal Cancer | Ovarian Cancer | Endometrial Cancer | Urothelial Cancer | Biliary Tract Cancer | Metastatic Castration-resistant Prostate CancerSpain, China, Korea, Republic of, Canada, Italy, Poland, Turkey, United Kingdom, Japan, Taiwan, United States, France, Germany, Switzerland
-
Centre Hospitalier Universitaire VaudoisActive, not recruitingProstate AdenocarcinomaSwitzerland
-
Centre Hospitalier Universitaire VaudoisTerminatedAdenocarcinoma of the ProstateSwitzerland
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyActive, not recruitingProstate CancerUnited States, Canada, Israel, Hong Kong, Singapore, Switzerland
-
PfizerCompletedProstatic NeoplasmsUnited States, Spain, Germany, Canada, United Kingdom, Switzerland
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Hormone-Sensitive Prostate CancerTaiwan, Poland, United States, Australia, Austria, Brazil, Canada, Chile, China, Colombia, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Peru, Russian Federation, Spai... and more
-
University Hospital Inselspital, BerneUniversity of Bern; Debiopharm International SA; Werner und Hedy Berger-Janser...RecruitingRecurrent Prostate CancerSwitzerland